NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
Clinical Trials
12 trialsNCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT02169765 2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT02646137 2018-01-09
Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
Tanta University
Phase 3 Unknown
NCT02568748 2017-04-27
Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC
Tanta University
Phase 3 Unknown
NCT01869088 2017-03-16
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT03010085 2017-01-04
OLLEH
Ewha Womans University Mokdong Hospital
Phase 3 Unknown
NCT00079027 2013-12-18
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00027768 2013-09-20
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01214343 2011-06-15
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
Ministry of Health, Labour and Welfare, Japan
Phase 3 Unknown
NCT01324076 2011-05-13
Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Unknown